A review of the association between oral bacterial flora and obstructive sleep apnea–hypopnea syndrome comorbid with cardiovascular disease
Tóm tắt
Obstructive sleep apnea–hypopnea syndrome (OSAHS), a common sleep disorder, has been shown to be an independent risk factor for cardiovascular disease (CVD). Recent studies have focused on the important roles of microorganisms in human health; for example, microorganisms are reportedly associated with obesity, metabolic disorders, and CVD. The number of oral bacteria in patients with OSAHS is considerably higher than that in healthy individuals, and infection with oral bacterial pathogens is associated with the development of CVD. However, whether changes in the oral microbiota mediate the development of OSAHS and CVD remains unknown. Therefore, we attempted to review the association between changes in oral microbiota in patients with OSAHS and the development of CVD. Oral microbiota possibly acts via multiple pathways including direct invasion, platelet aggregation, immune response, inflammatory response, and oxidative stress response, leading to the development of CVD in patients with OSAHS. In particular, the strains Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia have demonstrated profound effects. OSAHS leads to changes in the oral bacterial flora and thus may facilitate the occurrence and development of CVD. We propose that the underlying mechanism of CVDs resulting from oral microbiota in patients with OSAHS should be elucidated in further studies.
Tài liệu tham khảo
Azagra-Calero E, Espinar-Escalona E, Barrera-Mora JM, Llamas-Carreras JM, Solano-Reina E (2012) Obstructive sleep apnea syndrome (OSAS). Review of the literature. Med Oral Patol Oral Cir Bucal 17(6):925–929
Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290(14):1906–1914
Silverberg DS, Oksenberg A, Iaina A (1997) Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, under diagnosed, and undertreated. Am J Hypertens 10(12 Pt 1):1319–1325
Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283(14):1829–1836
Nizam N, Basoglu OK, Tasbakan MS, Lappin DF, Buduneli N (2016) Is there an association between obstructive sleep apnea syndrome and periodontal inflammation? Clin Oral Investig 20(4):659–668
Gunaratnam K, Taylor B, Curtis B, Cistulli P (2009) Obstructive sleep apnoea and periodontitis: a novel association? Sleep Breath 13(3):233–239
Seo WH, Cho ER, Thomas RJ, An SY, Ryu JJ, Kim H, Shin C (2013) The association between periodontitis and obstructive sleep apnea: a preliminary study. J Periodontal Res 48(4):500–506
DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM (1993) Dental disease and risk of coronary heart disease and mortality. BMJ 306(6879):688–691
Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M (2008) Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 23(12):2079–2086
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O’Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25
Basu S, Millett C (2013) Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 62(1):18–26
Goodfriend TL, Calhoun DA (2004) Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43(3):518–524
Calhoun DA, Nishizaka MK, Zaman MA, Harding SM (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125(1):112–117
Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277
Wang HW, Liu HM, Zheng ZY, Jia YZ, Li HR (2017) Effect of the obstructive sleep apnea hypopnea syndrome treatment on blood pressure in patients with resistant hypertension. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 52(1):49–52
Lu G, Xu ZW, Liu JN, Zhang YL, Yang ZJ, Zhang XL, Yin KS (2007) A study on the association of obstructive sleep apnea hypopnea syndrome with coronary atherosclerosis and coronary heart disease. Zhonghua Jie He He Hu Xi Za Zhi 30(3):178–181
Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med 173(8):910–916
Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, Amano A, Ooshima T (2009) Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol 24(1):64–68
Oliveira FA, Forte CP, Silva PG, Lopes CB, Montenegro RC, Santos ÂK, Sobrinho CR, Mota MR, Sousa FB, Alves AP (2015) Molecular analysis of oral bacteria in heart valve of patients with cardiovascular disease by real-time polymerase chain reaction. Medicine (Baltimore) 94(47):e2067
de Oliveira C, Watt R, Hamer M (2010) Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ 340:c2451
Fujita M, Ueno K, Hata A (2009) Lower frequency of daily teeth brushing is related to high prevalence of cardiovascular risk factors. Exp Biol Med 234(4):387–394
Tsioufis C, Kasiakogias A, Thomopoulos C, Stefanadis C (2011) Periodontitis and blood pressure: the concept of dental hypertension. Atherosclerosis 219(1):1–9
Aoyama N, Suzuki JI, Kumagai H, Ikeda Y, Akazawa H, Komuro I, Minabe M, Izumi Y, Isobe M (2018) Specific periodontopathic bacterial infection affects hypertension in male cardiovascular disease patients. Heart Vessel 33(2):198–204
Zhong LJ, Zhang YM, Liu H, Liang P, Murat AR, Askar S (2008) Detection of periodontal pathogens in coronary atherosclerotic plaques. Zhonghua Kou Qiang Yi Xue Za Zhi 43(1):4–7
Liljestrand JM, Paju S, Pietiäinen M, Buhlin K, Persson GR, Nieminen MS, Sinisalo J, Mäntylä P, Pussinen PJ (2018) Immunologic burden links periodontitis to acute coronary syndrome. Atherosclerosis 268:177–184
Sakurai K, Wang D, Suzuki J, Umeda M, Nagasawa T, Izumi Y, Ishikawa I, Isobe M (2007) High incidence of Actinobacillus actinomycetemcomitans infection in acute coronary syndrome. Int Heart J 48(6):663–675
Andriankaja O, Trevisan M, Falkner K, Dorn J, Hovey K, Sarikonda S, Mendoza T, Genco R (2011) Association between periodontal pathogens and risk of nonfatal myocardial infarction. Community Dent Oral Epidemiol 39(2):177–185
Suzuki J, Aoyama N, Aoki M, Tada Y, Wakayama K, Akazawa H, Shigematsu K, Hoshina K, Izumi Y, Komuro I, Miyata T, Hirata Y, Isobe M (2015) Incidence of periodontitis in Japanese patients with cardiovascular diseases: a comparison between abdominal aortic aneurysm and arrhythmia. Heart Vessel 30(4):498–502
Zaidi SJ, Husayni T, Collins MA (2018) Gemella bergeri infective endocarditis: a case report and brief review of literature. Cardiol Young 28(5):762–764
Chistiakov DA, Orekhov AN, Bobryshev YV (2016) Links between atherosclerotic and periodontal disease. Exp Mol Pathol 100(1):220–235
Ford PJ, Gemmell E, Hamlet SM, Hasan A, Walker PJ, West MJ, Cullinan MP, Seymour GJ (2005) Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol 20(5):296–302
Kato Y, Hagiwara M, Ishihara Y, Isoda R, Sugiura S, Komatsu T, Ishida N, Noguchi T, Matsushita K (2014) TNF-α augmented porphyromonas gingivalis invasion in human gingival epithelial cells through Rab5 and ICAM-1. BMC Microbiol 14:229
DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR (1997) Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 10(12 Pt 1):1335–1341
Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27(11):2292–2301
Lavie L (2015) Oxidative stress in obstructive sleep apnea and intermittent hypoxia-revisited-the bad ugly and good: implications to the heart and brain. Sleep Med Rev 20:27–45
Chandy S, Joseph K, Sankaranarayanan A, Issac A, Babu G, Wilson B, Joseph J (2017) Evaluation of C-reactive protein and fibrinogen in patients with chronic and aggressive periodontitis: a clinical biochemical study. J Clin Diagn Res 11(3):ZC41–ZC45
Wu CX, Liu Y, Zhang JC (2013) Chronic intermittent hypoxia and hypertension: a review of systemic inflammation and Chinese medicine. Chin J Integr Med 19(5):394–400
Dahiya P, Kamal R, Gupta R, Bhardwaj R, Chaudhary K, Kaur S (2013) Reactive oxygen species in periodontitis. J Indian Soc Periodontol 17(4):411–416
Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33(6):1467–1484